NCT03971500View on ClinicalTrials.gov

1-month vs 12-month DAPT for ACS Patients Who Underwent PCI Stratified by IVUS: IVUS-ACS and ULTIMATE-DAPT Trials

NAActive, not recruitingINTERVENTIONAL
Enrollment

3,710

Participants

Timeline

Start Date

August 20, 2019

Primary Completion Date

October 27, 2023

Study Completion Date

December 30, 2025

Conditions
Coronary Artery Disease
Interventions
DRUG

AntiPlatelet therapy

AntiPlatelet therapy with ticagrelor + aspirin or ticagrelor alone.

PROCEDURE

Percutaneous coronary intervention

PCI with DES implantation

Trial Locations (1)

210006

Nanjing First Hospital, Nanjing

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER

NCT03971500 - 1-month vs 12-month DAPT for ACS Patients Who Underwent PCI Stratified by IVUS: IVUS-ACS and ULTIMATE-DAPT Trials | Biotech Hunter | Biotech Hunter